SSB

Lupus La protein · P05455 · SSB on Sugi Atlas →

0 patent compounds predicted against SSB, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SSB by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial PHASE4RECRUITING
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II) PHASE3COMPLETED
A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) PHASE3ACTIVE_NOT_RECRUITING
Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care PHASE1/PHASE2COMPLETED
A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) PHASE2ACTIVE_NOT_RECRUITING
The Purpose of This Study is to Evaluate the Efficacy and Safety of 626 in the Treatment of SLE PHASE1/PHASE2RECRUITING
Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients PHASE2COMPLETED
JMKX000189 for Moderate to Severe Active Systemic Lupus Erythematosus PHASE2UNKNOWN
Telitacicept Study in Chinese Subjects With Systemic Lupus Erythematosus PHASE1COMPLETED
Omalizumab for Lupus PHASE1COMPLETED
Alnuctamab for Refractory SLE (LATTE Study) PHASE1RECRUITING
Study of AC0058TA in Patients With Systemic Lupus Erythematosus (SLE) PHASE1UNKNOWN
A Study of Telitacicept in Subjects With Childhood-onset Systemic Lupus Erythematosus PHASE1COMPLETED
A Study of LY3090106 in Participants With Sjögren's Syndrome (SS) PHASE1COMPLETED
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA) PHASE1RECRUITING
Safety and Efficacy Study of RXIM002 in Severe, Relapsed or Refractory Autoimmune Diseases EARLY_PHASE1RECRUITING
Follow-up Study of Individuals with Autoantibodies Against Ro/SSA and La/SSB nanRECRUITING
Value of Uric Acid as Early Predictor of Lupus Nephritis nanUNKNOWN
BAFF-var as a Biomarker of Response to B-depletive Treatment in Systemic Lupus Erythematosus and Rheumatoid Arthritis nanUNKNOWN
Clinical and Diagnostic Value of Ribosomal p2 Autoantibodies in Systemic Lupus Erythematosus nanUNKNOWN
Chinese Rheumatism Biobank(CRB) nanRECRUITING
The Research Registry for Neonatal Lupus nanCOMPLETED
The Clinical Course of Interstitial Pneumonia With Autoimmune Features nanCOMPLETED
The Effect of Exercise on Cognitive Functions in Individuals With Systemic Lupus Erythematosus nanNOT_YET_RECRUITING
Role of the Neonatal Fc Receptor for IgG in the Pathophysiology of Lupus nanCOMPLETED
A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases nanNOT_YET_RECRUITING
Occupational and Environmental Causes of Autoimmune Diseases nanCOMPLETED
Anti KU Antibodies and Its Relationship With Systemic Lupus Erythematosus nanUNKNOWN
Precision Medicine in LN: A Multicenter Proof-of-concept Study for Histopathological Biomarkers Analysis in Renal Biopsy nanUNKNOWN
Measurement of Anti-dsDNA by Both CLIFT & ELISA nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a SSB binder may also engage these)

ProteinNameSimilarity
P10881 1.000 P10881 →
P28048 0.997 P28048 →
P28049 0.996 P28049 →
P38656 0.992 P38656 →
P32067 0.990 P32067 →
Q26457 0.990 Q26457 →
P40796 0.990 P40796 →
P87058 0.987 P87058 →
Q93ZV7 0.977 Q93ZV7 →
P31669 0.976 P31669 →
Q6BH22 0.973 Q6BH22 →
Q9TRY0 0.973 Q9TRY0 →
A6ZPY2 0.972 A6ZPY2 →
P27124 0.972 P27124 →
Q09464 0.972 Q09464 →
P12262 0.971 P12262 →
O74503 0.971 O74503 →
Q5ZKC1 0.971 Q5ZKC1 →
P27008 0.971 P27008 →
Q5AI15 0.971 Q5AI15 →
Q7TMK9 0.971 Q7TMK9 →
SYNCRIP Heterogeneous nuclear ribonucleoprotein Q 0.971 landscape →
P33399 0.971 P33399 →
P26446 0.970 P26446 →
A5DGV3 0.970 A5DGV3 →
Q6CDH3 0.970 Q6CDH3 →
Q07205 0.970 Q07205 →
Q8T9B6 0.970 Q8T9B6 →
Q5AJS6 0.970 Q5AJS6 →
Q6DJI8 0.970 Q6DJI8 →